News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Roche (RHHBY) Settles Claims Over Genentech (RHHBY)'s Raptiva Psoriasis Drug, Lawyer Says


1/24/2012 8:37:45 AM

Roche Holdings AG (ROG) settled lawsuits claiming its Raptiva psoriasis drug caused infections, according to a lawyer for the plaintiffs. The lawyer, Mark Lanier, wouldn’t disclose the terms of the settlement today. Genentech withdrew the medication from the market almost three years ago. Genentech, a unit of Basel, Switzerland-based drugmaker Roche, was sued in state court in California over allegations that Raptiva caused Stephen Johnson’s death. The 46-year-old Louisiana businessman took the drug to treat a skin condition. That trial had been set to begin this month and was postponed last week to June, according to the case docket.

Read at Bloomberg


comments powered by Disqus
Bloomberg
Genentech
Roche
Roche
 
 
Psoriasis

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES